Definitive Healthcare Corp. (NASDAQ: DH) is -38.09% lower on its value in year-to-date trading and has touched a low of $14.76 and a high of $46.69 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DH stock was last observed hovering at around $16.78 in the last trading session, with the day’s gains setting it 0.14% off its average median price target of $29.50 for the next 12 months. It is also 50.24% off the consensus price target high of $34.00 offered by 11 analysts, but current levels are 26.43% higher than the price target low of $23.00 for the same period.
Currently trading at $16.92, the stock is -14.25% and -24.91% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.07 million and changing 0.83% at the moment leaves the stock -25.90% off its SMA200. DH registered -61.10% loss for a year compared to 6-month loss of -30.51%.
The stock witnessed a -17.02% gain in the last 1 month and extending the period to 3 months gives it a -23.09%, and is -13.01% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.30% over the week and 5.34% over the month.
Definitive Healthcare Corp. (DH) has around 676 employees, a market worth around $1.80B and $194.10M in sales. Fwd P/E is 50.66. Profit margin for the company is -16.20%. Distance from 52-week low is 14.63% and -63.76% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.10%).
Definitive Healthcare Corp. (DH) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Definitive Healthcare Corp. (DH) is a “Overweight”. 11 analysts offering their recommendations for the stock have an average rating of 2.20, where 5 rate it as a Hold and 1 think it is a “Overweight”. 5 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Definitive Healthcare Corp. is expected to release its quarterly report on 11/07/2022.The EPS is expected to grow by 44.20% this year
Definitive Healthcare Corp. (DH) Top Institutional Holders
The shares outstanding are 99.20M, and float is at 43.73M with Short Float at 9.09%.
Definitive Healthcare Corp. (DH) Insider Activity
A total of 28 insider transactions have happened at Definitive Healthcare Corp. (DH) in the last six months, with sales accounting for 14 and purchases happening 14 times. The most recent transaction is an insider sale by SEA VII Management, LLC, the company’s Director. SEC filings show that SEA VII Management, LLC sold 1,016,000 shares of the company’s common stock on Aug 09 at a price of $22.75 per share for a total of $23.11 million. Following the sale, the insider now owns 2.51 million shares.
Definitive Healthcare Corp. disclosed in a document filed with the SEC on Aug 08 that SEA VII Management, LLC (Director) sold a total of 1,100,000 shares of the company’s common stock. The trade occurred on Aug 08 and was made at $24.50 per share for $26.95 million. Following the transaction, the insider now directly holds 2.51 million shares of the DH stock.
Still, SEC filings show that on Aug 08, Winn David Randall (Director) disposed off 2,200,000 shares at an average price of $24.02 for $52.85 million. The insider now directly holds 0 shares of Definitive Healthcare Corp. (DH).
Definitive Healthcare Corp. (DH): Who are the competitors?
The company’s main competitors (and peers) include Microsoft Corporation (MSFT) that is trading -18.95% down over the past 12 months and International Business Machines Corporation (IBM) that is -1.64% lower over the same period. General Electric Company (GE) is -32.64% down on the 1-year trading charts.